[Other] Felzartamab plus lenalidomide每dexamethasone versus lenalidomide每dexamethasone for relapsed or refractory multiple myeloma: an open-label, parallel-controlled, randomised, phase 3 trial

JScienceK Post time Yesterday 23:19 | Show all posts |Read mode
This post will be closed automatically in 2026-10-05 23:18
Reward100points

Felzartamab plus lenalidomide每dexamethasone versus lenalidomide每dexamethasone for relapsed or refractory multiple myeloma: an open-label, parallel-controlled, randomised, phase 3 trialLancet Haematol




. 2026 Oct;13(10):e722-e736.


https://pubmed.ncbi.nlm.nih.gov/42822478/


https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00223-1/abstract





Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
sunnydanesh Post time Yesterday 23:19 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list